Post-Ablation Pericarditis Reduction Study (PAPERS)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 248 participants.

Also called NCT06731595

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 248 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06731595
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06731595. Randomized; no masking; primary purpose prevention. Start 2021-05-20 (actual); primary completion 2022-01-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-Ablation Pericarditis Reduction Study (PAPERS)
Acronym
PAPERS
Condition
Pericarditis
Intervention (Drug)
Colchicine
Lead sponsor
St. Vincent Cardiovascular Research Institute (class: other)
Collaborator
Asenson Sacred Heart - Pensacoloa, FL (class: not stated)

Record details

Record id
cardio:ct-nct06731595
Content hash
61f0441645506007d6eb9fa0afa5fb5f479474dcade8450181847040c4c2f1c2